The TechBio way: Brendan Frey talks genomics, AI, and RNA
pharmaphorum speaks with Brendan Frey, founder and chief innovation officer of Deep Genomics, an AI-first TechBio organisation.
Under pressure from Trump, Lilly hikes Mounjaro prices in UK
Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro to bring it into parity with other European markets.
NHS cleared to use AZ's Fasenra for rare autoimmune disease
NICE backs NHS use of an AstraZeneca drug for one rare disease, but says it can't recommend a BioMarin therapy for another.
Artera gets FDA okay for prostate cancer AI
A newly approved AI from Artera can guide treatment and predict prognosis in people diagnosed with localised prostate cancer.
Featured Content
Editor's Picks
Editor's Picks
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
7th TIL Therapies Summit
Driving the Next Generation of TIL Therapies for Solid Tumors
3rd Donor Selection & Cell Source Summit
Transforming Off-The-Shelf Therapies From the Start
LEAP TA: Life Sciences
Reimagine Hiring Tactics to Compete for the Best Life Sciences Talent
MASH Drug Development Summit
Advancing Efficacious MASH Therapeutics in the Evolving Metabolic Landscape
2nd World Companion Diagnostics & Liquid Biopsy Summit APAC
The Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies